Peri-Operative Chemotherapy in the Management of Resectable Colorectal Cancer Pulmonary Metastases

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-12-326
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Peri-Operative Chemotherapy for the Treatment of Resectable Liver Metastases From Colorectal Cancer: A Systematic Review and Meta-Analysis of Randomized Trials

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Evaluation of Peri-Operative Chemotherapy Using a Prognostic Nomogram for Survival After Resection of Colorectal Liver Metastases

HPB
HepatologyGastroenterology
2009English

Pre-Operative Chemotherapy for Colorectal Cancer Liver Metastases: An Update of Recent Clinical Trials

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2010English

Nutrition in Peri-Operative Esophageal Cancer Management

Expert Review of Gastroenterology and Hepatology
HepatologyGastroenterology
2017English

Adjuvant Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Pulmonary Metastases From Colorectal Cancer.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2013English

Adjuvant Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Pulmonary Metastases From Colorectal Cancer

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2014English

Survival Prediction in Patients With Resectable Colorectal Liver Metastases: Clinical Risk Scores and Tumor Response to Chemotherapy

Oncology Letters
Cancer ResearchOncology
2017English

Total Tumour Volume as a Prognostic Factor in Patients With Resectable Colorectal Cancer Liver Metastases

BJS open
Surgery
2020English

Management of Peritoneal Metastases of Colorectal Cancer, Literature Review

Journal of Cancer Prevention & Current Research
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy